Laurus Labs (BOM:540222) Short Interest


BOM:540222 Laurus Labs Ltd BOM:540222
66 GF Score
Price ₹1,493.60
GF Value ₹700.37
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Laurus Labs Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

BOM:540222 vs ZTS, UTHR: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Laurus Labs's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Laurus Labs Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Laurus Labs's Short Interest distribution charts can be found below:

* The bar in red indicates where Laurus Labs's Short Interest falls into.


BOM:540222
66GF Score
Laurus Labs Ltd BOM:540222
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Laurus Labs (BOM:540222) Overvalued in 2026?

Based on GuruFocus' analysis, Laurus Labs stock appears to be overvalued. The current stock price of ₹1,493.60 is trading 113.3% above its estimated GF Value™ of ₹700.37. GuruFocus considers Laurus Labs to be Significantly Overvalued.

Key valuation signals for BOM:540222:

  • Short Interest:
  • GF Value™: ₹700.37 vs. price of ₹1,493.60 (113.3% above fair value)
  • GF Score™: 66/100 with 5 warning signs

No single metric tells the full story. See the BOM:540222 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Laurus Labs Business Description

Other Exchanges LAURUSLABS:India
Address Road No.1, Jubilee Hills, Plot No.103, Hyderabad, TG, IND, 500033
Laurus Labs Ltd is a pharmaceutical company based in India. It provides active pharmaceutical ingredients (API) including intermediates, Generic Finished dosage forms (FDF), and Contract Research services. The entity develops APIs and intermediates for select, high-growth antiretrovirals, Hepatitis C and Oncology. It also manufactures APIs in other therapeutic areas, such as anti-asthma, ophthalmology, anti-diabetics, cardiovascular, and proton pump inhibitors, among others. The company has its business presence in India and Outside India of which it derives a majority of revenue from Outside India. The company generates revenue from the sale of API, Intermediates and Formulations, Contract research services, and others.
66GF Score

Get the complete analysis for BOM:540222

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,493.60
Price
₹700.37
GF Value